3d Printed Drug
Hi zintro expert,
the zintro blog needs you! we are looking for expert opinions on the news mentioned below and would like to include your point of view. We realize your time is valuable, so here is a brief summary of what we are looking for:
*a brief answer to the prompt about 1-2 paragraphs including your full name
*participation is voluntary no payment will be involved
*if chosen, you will be named in the post and we'll include a link to your zintro profile which will generate more visitors for you
topic and prompt
this week the us food and drug administration (fda) gave the go ahead to the first 3d-printed drug, spritam, which is designed to treat seizures brought on by epilepsy in adults and children. It was developed using zipdose, a 3d printer that creates ills by printing out thin layers of medicine in powder form, with layers of a water-based binder spread between each of the powder layers. The result is a tablet that can dissolve with a sip of water in less than five seconds. Spritam will be commercially available from early 2016 onwards.
Do you think 3d-printed drugs could have the ability to transform the pharmaceuticals industry.
Getting your name and expert opinion published on our blog is a great marketing opportunity. If interested, please send a response to the prompt via znotes within 1-2 days. Don't forget to include your full name.
If you have any questions, please let us know.
the zintro blog team
wondering what the post would look like? Here is a sample:
/>+3 Other Responses
i am looking to understand the distribution mark-up of immunosuppressive drugs in europe by pharma companies in a marketing and distribution agreement
regards,arun+6 Other Responses
Indian Generic Drugs Space
We are a global consulting firm currently working on a mandate in the indian generic drugs space.
We are looking to connect with experts having extensive prior experience in the strategy, commercial and r&d functions of indian generic manufacturers with presence in usa retail market and having own api manufacturing setup.
Experience/knowledge of the following topics:
- emerging and high growth areas (therapeutic areas or api product type) in the api space in india and other emerging markets, the us and european market.
- capabilities required to succeed in specific markets and specific therapeutic areas.
- overview on key players in api generics space and various business models adopted by large, midsize and small players (e.G., api focus with formulation add-on's, therapeutic area focus).
Please respond with your relevance to this request and your availability for a paid phone consultation this week.+20 Other Responses
Drug Discovery Outsourcing
I am performing a study on the market of drug discovery outsourcing (specific to cancer immunotherapy).
I need to know the applications of biomarkers in cancer immunotherapy drug discovery. Additionally, the costs involved in outsourcing in vivo procedures such as pk/pd and efficacy testing.+16 Other Responses